Skip to main content
SpringerLink
Log in

NK 1.1+ T Cell: A Two-Faced Lymphocyte in Immune Modulation of the IL-4/IFN-γ Paradigm

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

T lymphocytes expressing NK1.1 marker (NK1.1+) have been suggested as being important in peripheral immune modulation. Alteration of the balance between Th1 proinflammatory and Th2 anti-inflammatory cytokine-producing cells can ameliorate immune-mediated disorders. The aim of the study was to determine the role of NK1.1+ lymphocytes in the pathogenesis of tolerance and proinflammatory states and to determine their role in altering the Th1/Th2 balance in experimental colitis. Colitis was induced in C57/B6 mice by intracolonic instillation of trinitrobenzenesulfonic acid (TNBS). Mice received five oral doses of colonic proteins extracted from TNBS colitis colonic wall. Standard clinical, macroscopic, and microscopic scores were used for colitis assessment. Liver-associated lymphocytes and splenocytes were harvested 14 days following tolerance induction. Depletion of NK 1.1+ lymphocytes was performed 36 hr before lymphocyte harvesting. Lymphocytes were cultured for 12 hr with Con A and colitis extracted proteins. To evaluate the role of NK1.1+ lymphocytes in keeping a balance between immunogenic and tolerogenic subsets of cells, intracellular staining and flow cytometry assays were performed in tolerized and nontolerized mice. IL-4, IL-12, and IFN-γ levels were measured by ELISA. Administration of mouse-derived colitis-extracted proteins ameliorated experimental colitis. Tolerized mice exhibited significant improvement in all macroscopic and microscopic parameters for colitis. Depletion of NK1.1 following tolerance induction significantly decreased the CD4+IL-4+/CD4+IFN-γ+ ratio in tolerized mice. However, depletion of NK1.1 lymphocytes in nontolerized mice increased the CD4+IL-4+/CD4+IFN-γ+ ratio, compared with nondepleted nontolerized mice. Induction of tolerance led to an increase in IL4 and a decrease in IFN-γ levels. In the experimental colitis model NK1.1+ lymphocytes play a dual role: In the presence of peripheral tolerance they may be accountable for keeping the high CD4+IL-4+/CD4+IFN-γ+ ratio and disease alleviation. However, in nontolerized conditions they may induce a proinflammatory shift.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. MacDonaland RH: NK1.1+ T cells: New clues to their origin, specificity and function. J Exp Med 182:633–638, 1995

    Google Scholar 

  2. Bendelac A: Mouse NK1.1+ T cells. Curr Opin Immunol 7:367–374, 1995

    Google Scholar 

  3. Weiner HL: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335–343, 1997

    Google Scholar 

  4. Strobel S, Mowat AM: Immune response to dietary antigens: Oral tolerance. Immunol Today 4:173–181, 1998

    Google Scholar 

  5. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Anderson CN, Bhan AK: Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 183:847–856, 1996

    Google Scholar 

  6. Strober W, Kelsall B, Fuss L, Marth T, Ludviksson B, Ehrhardt R, Neurath M: Reciprocal IFN-γ and TGF β responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61–64, 1997

    Google Scholar 

  7. Neurath M, Kelasall BL, Presky DH, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 183:2605–2616, 1996

    Google Scholar 

  8. Madsen KL, Lewis Simon A, Tavernini MM, Hibbard J, Fedorak RN: Interleukin 10 prevents cytokine-induced disruption of T84 barrier integrity and limits chloride secretion. Gastroenterology 113:151–159, 1997

    Google Scholar 

  9. Van Deventer Sander J, Charles O, Fedorak RN: Multiple doses of intravenous interleukin 10 in steroid refractory Crohn' disease. Gastroenterology, 113:383–389, 1997

    Google Scholar 

  10. Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, Roy Chowdhury N, Roy Chowdhury J, Goldin E: Treatment of experimental colitis by oral tolerance induction: A central role for suppressor lymphocytes. Am J Gastroenterol 95:966–973, 2000

    Google Scholar 

  11. Trop S, Samsonov D, Gotsman I, Alper R, Diment J, Ilan Y: Liver associated lymphocytes expressing NK1.1 are essential for oral tolerance induction in a murine model. Hepatology 29:746–755, 1999

    Google Scholar 

  12. Ilan Y, Sauter B, Roy Chowdhury N, Reddy BVN, Thummala NR, Droguett G, Davidson A, Ott M, Horwitz MS, Roy Chowdhury J: Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirus. Hepatology 27:1368–1376, 1998

    Google Scholar 

  13. Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V. The NK1.1-mouse: A model to study differentiation of murine NK cells. J Immunol 137:3742–3747, 1988

    Google Scholar 

  14. Wynn AT, Reynolds A, James S, Cheever AW, Caspar P, Hieny S, Jankovic D, Strand M, Sher A: IL-12 enhances vaccine-induced immunity to Schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 157:4068–4078, 1996

    Google Scholar 

  15. Crispe N, Mehal WZ. Strange brew: T cells in the liver. Immun Today 11:236–245, 1996

    Google Scholar 

  16. Collins C, Norris S, McEntee G, Traynor O, Bruno L, Von Boehmer H, Hegarty J, O'Farrelly C: RAG1, RAG2 and pre-T cell receptor α chain expression by adult human hepatic T cells: Evidence for extrathymic T cell maturation. Eur J Immunol 26:3114–3118, 1996

    Google Scholar 

  17. Tsukahara A, Seki S, Liai T, Moroda T, Watanabe H, Suzuki S, Tada T, Hiraide H, Hatakeyama K, Abou T: Mouse liver T cells: Their change with aging and in comparison with peripheral T cells. Hepatology 26:301–311, 1997

    Google Scholar 

  18. Arase H, Arase-Fukushi N, Good RA Onoe K: Lymphokineactivated killer cell activity of CD4-CD8-TCRαβ+ thymocytes J Immunol 151:546, 1993

    Google Scholar 

  19. Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Yagita H, Abo T, Okumura K: Critical role of NK1.1 T cells in IL12-induced immune responses in vivo. J Immunol 160:16–19

  20. Gotsman I, Jurim O, Trop S, Pappo O, Ilan Y: The effect of peripheral immune tolerance induction on liver-associatedlymphocytes expressing NK1.1. Transplant Proc 32:749–750, 2000

    Google Scholar 

  21. Samsonov D, Trop S, Alper R, Diment J, Ilan Y:Enhancement of immune tolerance via induction of NK1.1 positive liverassociated-lymphocytes under immunosuppressive conditions in a murine model. J Hepatol 32:812–820, 2000

    Google Scholar 

  22. Miller A, Lider O, Roberts AB, Sporn M, Weiner HL: Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc Natl Acad Sci USA 89:421–425, 1992

    Google Scholar 

  23. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA: Double-blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science 261:1321–1324, 1993

    Google Scholar 

  24. Von Herrath MG, Dyrberg T, Oldstone MBA: Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324–1331, 1996

    Google Scholar 

  25. Ilan Y, Prakash R, Davidson A, Jona VK, Droguett G, Horwitz MS, Roy Chowdhury N, Roy Chowdhury J: Oral tolerization to adenoviral antigens permits long term gene expression using recombinant adenoviral vectors. J Clin Invest 99:1098–1106, 1997

    Google Scholar 

  26. Takahashi M, Ilan Y, Sengupta K, Roy Chowdhury N, Roy Chowdhury J: Induction of tolerance to recombinant adenoviruses by injection into newborn rats: Long term amelioration of hyperbilirubinemia in Gunn rats. J Biol Chem 271:26536–26542, 1996

    Google Scholar 

  27. Ilan Y, Jona VK, Sengupta K, Davidson A, Horwitz MS, Roy Chowdhury N, Roy Chowdhury J: Transient immunosuppression with FK506 permits long term expression of therapeutic genes introduced into the liver using recombinant adenoviruses. Hepatology 26:949–956, 1997

    Google Scholar 

  28. Ilan Y, Droguett G, Roy Chowdhury N, Yongan L, Sengupta K, Thummala NR, Davidson A, Roy Chowdhury J, Horwitz MS: Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long term gene expression. Proc Nat Acad Sci USA 94:2587–2592, 1997

    Google Scholar 

  29. Ilan Y, Attavar P, Takahashi M, Davidson A, Horwitz M, Guida J, Roy Chowdhury N, Roy Chowdhury J: Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long term gene therapy in Gunn rats. J Clin Invest 98:2640–2647, 1996

    Google Scholar 

  30. Ilan Y, Roy Chowdhury N, Sauter B, Thummala NR, Horwitz MS, Davidson A, Nakamura J, Fox IJ, Roy Chowdhury J: A critical role of the liver in inducing oral tolerance to adenoviral vectors for long-term gene therapy. Gastroenterology 114:260A, 1998

    Google Scholar 

  31. Viola A, Schroder S, Sakakibara Y, Lanzavecchia A: T lymphocyte costimulation by reorganizaion of membrane domains. Science 283:680–682, 1999

    Google Scholar 

  32. Doherty DG, Norris S, Collins C, McEntee G, Traynor O, Hegarty J, O'Farrelly C: Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Vα24-JαQ and γδ T cell receptor bearing cells. Human Immunol 60:20–31, 1999

    Google Scholar 

  33. Jonsson JR, Edwards-Smith CJ, Morotomi Y, Hogan PG, Clouston AD, Lynch SV, Strong RW, Powell EE: Expression of Fas/FasL and bcl2 in normal human liver derived leukocytes. Hepatology 26:269A, 1997

    Google Scholar 

  34. Arase H, Arase N, Kobayashi Y, Nishimura Y, Yonehara S Onoe K: Cytotoxicity of fresh NK1.1 T cells receptor α/β+ thymocytes against a CD4+ CD8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 180:423, 1994

    Google Scholar 

  35. Tamada K, Harada M, Abe K. NK1.1+ T cells established from murine tumor-infiltrating lymphocytes. J Immunol 158:4846–4851, 1995

    Google Scholar 

  36. Onoe Y, Harada M, Tamada K, Abe K, Li T, Tada H, Nomoto K: Involvement of both donor cytotoxic lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease. Immunology 95:248–256, 1998

    Google Scholar 

  37. Neurath MF; Fuss I, Kelsall BL, Stuber E, Strober W: Antibodies to IL-12 abrogate established experimental colitis in mice. J Exp Med 182:1281–1290, 1995

    Google Scholar 

  38. Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I: Activation of mouse liver natural killer cells and NK1.1+ T cells by bacterial superantigen-primed Kupffer cells. Hepatology 30:430–436, 1999

    Google Scholar 

  39. Siveke JT, Hamann ALF: T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 160:550–554, 1998

    Google Scholar 

  40. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Pericudet M, Tursz T, Marasokovsky E, Zitvogel L: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405–411, 1999

    Google Scholar 

  41. Dao T, Mehal WZ, Crispe IN: IL18 augments perforin-dependent cytotoxicity of liver NKT cells. J Immunol 161:2217–2222, 1998

    Google Scholar 

  42. Emoto M, Mittrucker HW, Schmits R, Mak TW, Kaufmann SHE: Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+ NKT cells. J Immunol 162:5094–5098, 1999

    Google Scholar 

  43. Porceli SA, Brenner MB: Antigen presentation: Mixing oil and water. Curr Biol 7:508–513, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Liver Unit, Department of Medicine, Hadassah University Hospital, Jerusalem, Israel, IL-91120

    Shivti Trop & Yaron Ilan

Authors
  1. Shivti Trop
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yaron Ilan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trop, S., Ilan, Y. NK 1.1+ T Cell: A Two-Faced Lymphocyte in Immune Modulation of the IL-4/IFN-γ Paradigm. J Clin Immunol 22, 270–280 (2002). https://doi.org/10.1023/A:1019974005134

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019974005134

Search

Navigation